Can I Take Vitamin B12 with Synthroid (Levothyroxine)?

No Direct Interaction Between Levothyroxine and Vitamin B12

Levothyroxine and vitamin B12 do not compete for the same absorption pathways, do not alter each other's metabolism, and do not produce additive or opposing pharmacodynamic effects. The two substances are safe to use together.

Why There Is No Pharmacokinetic Conflict

Levothyroxine (T4) is a synthetic thyroid hormone absorbed primarily in the jejunum and upper ileum, with peak absorption occurring in an acidic gastric environment on an empty stomach [1]. Vitamin B12, by contrast, requires intrinsic factor produced by gastric parietal cells and is absorbed in the terminal ileum through a receptor-mediated process that is entirely separate from T4 uptake [2]. Because these two agents rely on different transport proteins, different intestinal segments, and different pH-dependent mechanisms, co-administration does not produce a pharmacokinetic clash.

No Pharmacodynamic Overlap

Pharmacodynamically, levothyroxine acts on nuclear thyroid receptors to regulate basal metabolic rate, thermogenesis, and protein synthesis. Vitamin B12 serves as a cofactor for methionine synthase and methylmalonyl-CoA mutase, enzymes involved in DNA synthesis, myelin maintenance, and red blood cell maturation [3]. These pathways do not intersect in a way that would create synergistic toxicity or mutual antagonism.

The Natural Medicines Comprehensive Database and the American Thyroid Association (ATA) do not list vitamin B12 as a substance that interferes with levothyroxine absorption or efficacy [4]. This stands in sharp contrast to calcium, iron, and aluminum-containing antacids, all of which form insoluble complexes with T4 and reduce its bioavailability.

Why Hypothyroid Patients Should Still Pay Attention to B12

Even though B12 does not interact with levothyroxine directly, hypothyroid patients have a higher-than-average risk of B12 deficiency. Understanding why matters for symptom management.

Autoimmune Overlap

Hashimoto's thyroiditis, the most common cause of hypothyroidism in iodine-sufficient countries, is an autoimmune condition. Autoimmune diseases cluster. A 2009 cross-sectional study published in the Journal of the Pakistan Medical Association found that roughly 40% of patients with autoimmune thyroid disease had coexisting B12 deficiency [5]. Pernicious anemia, the autoimmune destruction of gastric parietal cells that eliminates intrinsic factor production, shares HLA-DR associations with Hashimoto's thyroiditis.

The Metformin Connection

Many patients with hypothyroidism also carry a diagnosis of type 2 diabetes or insulin resistance and take metformin. Long-term metformin use (over 3 years, doses of 1,500 mg/day or higher) reduces B12 absorption by interfering with calcium-dependent ileal uptake of the B12-intrinsic factor complex [6]. A randomized, placebo-controlled trial (DPP/DPPOS, N=2,155) demonstrated that metformin users had significantly lower B12 levels compared to placebo after a median follow-up of 13 years, with 4.3% developing biochemical B12 deficiency [7].

If you take levothyroxine AND metformin, you sit at the intersection of two independent risk factors for low B12: autoimmune gastric pathology and metformin-mediated malabsorption. This combination warrants proactive monitoring rather than reactive testing after symptoms appear.

Symptom Overlap Makes Clinical Detection Harder

B12 deficiency causes fatigue, cognitive sluggishness, cold intolerance, and constipation. So does undertreated hypothyroidism. When a patient on levothyroxine reports persistent fatigue despite a normal TSH, clinicians sometimes adjust the T4 dose instead of checking B12. A 2013 article in the British Medical Journal noted that neuropsychiatric manifestations of B12 deficiency (paresthesias, balance problems, memory impairment) can occur even at serum B12 levels that are technically within the "normal" lab range of 200 to 900 pg/mL [8]. Methylmalonic acid (MMA) is more sensitive for detecting tissue-level B12 insufficiency.

Timing and Dose-Separation Best Practices

Even with no direct interaction, levothyroxine's finicky absorption profile means timing still matters. The drug's bioavailability drops by up to 40% when taken with food compared to a fasting state [9].

The Standard Rule

The ATA recommends taking levothyroxine on an empty stomach, ideally 30 to 60 minutes before the first meal of the day, with a full glass of water [4]. No other medications or supplements should be taken during this window.

Where B12 Fits

Oral vitamin B12 (cyanocobalamin or methylcobalamin) can be taken with or without food. It does not require an acidic environment for absorption when taken in pharmacologic doses above 200 mcg, because passive diffusion across the intestinal mucosa becomes the dominant uptake route at high doses [2]. The practical recommendation: take your levothyroxine first thing in the morning, wait at least 30 to 60 minutes, then take B12 with breakfast or at any other convenient time during the day.

Sublingual and Injectable B12

Sublingual B12 tablets dissolve under the tongue and enter the bloodstream through the oral mucosa, bypassing the GI tract entirely. A 2003 study in the British Journal of Clinical Pharmacology (N=30) found sublingual cyanocobalamin 500 mcg daily was as effective as intramuscular injection for correcting B12 deficiency [10]. Neither sublingual nor intramuscular B12 has any theoretical mechanism for altering levothyroxine absorption.

Monitoring Recommendations

Routine monitoring ensures that both thyroid replacement and B12 status remain optimized, especially when risk factors for deficiency overlap.

For Levothyroxine

TSH should be checked 6 to 8 weeks after any dose change and at least annually once stable. Free T4 can be added if TSH is discordant with clinical presentation [4].

For Vitamin B12

The Endocrine Society and the ADA recommend annual B12 screening for all patients on long-term metformin [11]. For hypothyroid patients without metformin use but with autoimmune thyroid disease, checking serum B12 at baseline and when symptoms of deficiency appear is reasonable. Order MMA if serum B12 falls between 200 and 400 pg/mL, a range where functional deficiency can exist despite a "normal" lab value [8].

Red Flags That Warrant Immediate Testing

New-onset peripheral neuropathy (tingling, numbness in hands or feet), unexplained macrocytic anemia (MCV above 100 fL), or cognitive changes that do not improve after TSH normalization all warrant a B12 panel. Untreated B12 deficiency can cause irreversible subacute combined degeneration of the spinal cord [3].

What If You Are Already Taking Both?

If you are currently taking levothyroxine and vitamin B12 together and your TSH has been stable, there is no reason to change your regimen. The absence of interaction means historical co-administration has not been silently undermining either medication.

Dose Adjustments

No dose adjustment of levothyroxine is needed when adding or removing B12 supplementation. No dose adjustment of B12 is needed when starting or changing levothyroxine doses.

Switching B12 Forms

Switching between cyanocobalamin and methylcobalamin does not alter the interaction profile with levothyroxine. Methylcobalamin is the bioactive form and may be preferred in patients with MTHFR polymorphisms, though clinical evidence for superiority over cyanocobalamin in the general population is limited [12].

Supplements That DO Interact with Levothyroxine

For context, here is what actually requires caution. These substances should be separated from levothyroxine by at least 4 hours:

• Calcium carbonate and calcium citrate: bind T4 in the gut, reducing absorption by 20 to 25% [13]
• Ferrous sulfate (iron): forms an insoluble iron-T4 complex, cutting absorption significantly [14]
• Aluminum and magnesium hydroxide antacids: raise gastric pH and chelate T4 [1]
• Cholestyramine and colestipol: bile acid sequestrants that trap T4 in the intestinal lumen [4]
• Sevelamer: a phosphate binder used in chronic kidney disease that binds T4 [15]
• Proton pump inhibitors (PPIs): chronic PPI use may reduce T4 absorption by raising gastric pH, though data are mixed [16]

Vitamin B12 is not on this list. It does not bind, chelate, sequester, or alter the pH environment in a way that affects T4.

B12 Dosing Guidance for Hypothyroid Patients

Appropriate B12 dosing depends on baseline levels and the reason for supplementation.

Maintenance Supplementation

For patients with adequate B12 levels who want to maintain status (particularly those over age 50, who absorb food-bound B12 less efficiently), 500 to 1,000 mcg of oral cyanocobalamin or methylcobalamin daily is the standard recommendation from the Office of Dietary Supplements at the NIH [17].

Correcting Documented Deficiency

For serum B12 below 200 pg/mL with or without symptoms, high-dose oral replacement (1,000 to 2,000 mcg daily) for 8 to 12 weeks followed by maintenance dosing is effective in most cases. A Cochrane review confirmed that high-dose oral B12 is non-inferior to intramuscular injections for correcting deficiency in patients without intrinsic factor antibodies [18].

Pernicious Anemia

Patients with confirmed pernicious anemia (positive intrinsic factor antibodies) require intramuscular or high-dose oral B12 (1,000 to 2,000 mcg daily) indefinitely, as standard dietary intake cannot overcome the absence of intrinsic factor-mediated absorption at physiologic doses [3].

Special Populations

Pregnant Patients on Levothyroxine

Thyroid hormone requirements increase by 30 to 50% during pregnancy, and B12 demand rises to support fetal neural tube development [19]. Both levothyroxine dose escalation and B12 adequacy should be confirmed early in the first trimester. The two can continue to be taken together without interaction concerns.

Older Adults

Adults over 65 have a higher prevalence of both hypothyroidism (up to 10% of women over 60) and B12 malabsorption due to atrophic gastritis [17]. Annual screening for both TSH and B12 is efficient and supported by guidelines from the U.S. Preventive Services Task Force for B12 and the ATA for thyroid function [4].

Patients After Bariatric Surgery

Roux-en-Y gastric bypass reduces absorptive surface area for both levothyroxine and B12. These patients often require higher levothyroxine doses and lifelong parenteral or high-dose oral B12 supplementation [20]. TSH and B12 should be monitored every 3 to 6 months in the first post-surgical year.